How The Quality Culture Impacts GMP Activity

A robust quality culture in the biopharmaceutical sector is characterized by all members of the organization comprehending the significance of patient safety and recognizing how their individual roles influence associated risks. It prioritizes decisions based on ensuring patient safety above all else. From a GMP standpoint, this entails not only adhering to formal regulations but also staying abreast of the latest best practices, grasping the potential risks posed by the company's processes and products to patients, and integrating efficient quality risk management procedures.

About The Speaker: Londa Ritchey is Quality Director with the Quality Management and Compliance group at PharmaLex.